Novo Nordisk's 'long game' on weight loss drugs sparks hope in science, but the Street is impatient
诺和诺德诺和诺德(US:NVO) CNBC·2025-12-30 06:12

Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood sugar. (Photo by Steve Christo - Corbis/Corbis via Getty Images)Steve Christo - Corbis | Corbis News | Getty ImagesNovo Nordisk has had a difficult year: a tumbling stock price resulting in the biggest leadership shakeup in the company's 100-year history as investors turned their back on the Danish drugmaker and its weight loss business. It seemed investors had largely given up on Novo's ability to transl ...